会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • SYSTEM FOR IMPLEMENT DRAFT REDUCTION
    • 执行减速系统
    • WO2008095503A1
    • 2008-08-14
    • PCT/DK2008/050026
    • 2008-02-06
    • Aarhus UniversitetGREEN, OleJØRGENSEN, Rasmus Nyholm
    • GREEN, OleJØRGENSEN, Rasmus Nyholm
    • A01B63/02A01B63/24A01B63/28A01B63/30A01B63/32A01B79/00A01B63/00
    • A01B79/00A01B63/245
    • There is disclosed a system and method of reducing draft forces when working soil with agricultural soil working implements (206, 211) creating draft forces, the soil working implements (208, 206, 211) beingoperable connectable to a frame (204, 304, 404, 504, 604, 704) and moveable in a working direction, the frame having a working width (212), the method comprising working the soil in a first part (222) of the width (212), the first part of said width being smaller than the width (212), and hereafter working the soil in a second part (220) of the width, the second part of the width comprising an other part of said width (212) than the first part (222), so as e.g. to reduce draft forces compared to working both first and second parts at the same time.
    • 公开了一种系统和方法,该系统和方法在用农用土工作工具(206,211)施工土壤时减少牵引力,产生牵引力,土壤作业工具(208,206,211)可操作地连接到框架(204,304,404) ,504,604,704),并且可在工作方向上移动,所述框架具有工作宽度(212),所述方法包括在所述宽度(212)的第一部分(222)中对所述土壤进行加工,所述宽度的第一部分 小于宽度(212),并且此后在宽度的第二部分(220)中操作土壤,宽度的第二部分包括比第一部分(222)所述宽度(212)的另一部分,因此 例如 以减少与第一和第二部分同时工作的牵引力。
    • 6. 发明申请
    • METHOD FOR OPTIMIZING HARVESTING OF CROPS
    • 优化采收方法
    • WO2010003421A1
    • 2010-01-14
    • PCT/DK2009/050150
    • 2009-06-26
    • Aarhus UniversitetSyddansk UniversitetGREEN, OleJØRGENSEN, Rasmus NyholmGISLUM, RenéSØRENSEN, Claus Aage Grøn
    • GREEN, OleJØRGENSEN, Rasmus NyholmGISLUM, RenéSØRENSEN, Claus Aage Grøn
    • A01B79/00A01D41/127
    • A01D91/04A01B79/005
    • In order e.g. to optimize harvesting crops of the kind which may be self dried on a field prior to a harvesting step (116, 118), there is disclosed a method of providing a mobile unit (102) for working (114, 116, 118) the field with crops, equipping the mobile unit (102) with crop biomass measuring means (108) and with crop moisture content measurement means (106), measuring crop biomass (107a, 107b) and crop moisture content (109a, 109b) of the crop, providing a spatial crop biomass and crop moisture content characteristics map of the field based on the biomass data (107a, 107b) provided from moving the mobile unit on the field and the moisture content (109a, 109b), and determining an optimised drying time (104a, 104b) prior to the following harvesting step (116, 118) in response to the spatial crop biomass and crop moisture content characteristics map and in response to a weather forecast (110).
    • 例如 为了优化在收获步骤(116,118)之前在田地上可能自干的种类的收割作物,公开了一种提供用于工作的移动单元(114,116,118)的方法, 用作物装备移动单元(102)作物生物量测量装置(108)和用作物水分含量测量装置(106),测量作物的作物生物量(107a,107b)和作物水分含量(109a,109b) 基于从现场移动移动单元和水分含量(109a,109b)提供的生物量数据(107a,107b)提供空间作物生物量和作物水分含量特征图,并确定优化的干燥时间( 104a,104b),在响应于空间作物生物量和作物水分含量特征图以及响应于天气预报(110)之后,在随后的收获步骤(116,118)之前。
    • 8. 发明申请
    • MODIFIED RECEPTORS FOR THE DISCOVERY OF THERAPEUTIC LIGANDS
    • WO2003055914A3
    • 2003-07-10
    • PCT/DK2002/000900
    • 2002-12-20
    • 7TM PHARMA A/SSCHWARTZ, Thue, W.MARTINI, LeneHEYDORN, ArneJØRGENSEN, Rasmus
    • SCHWARTZ, Thue, W.MARTINI, LeneHEYDORN, ArneJØRGENSEN, Rasmus
    • C07K14/705
    • A drug discovery method for selecting a compound selected from the group consisting of a small organic substance, a biopharmaceutical and an antibody or part thereof. The method comprises the steps of i) expressing one or more receptors on a cell membrane, such as, e.g., an exterior cell surface of a cell, ii) contacting one or more expressed receptors with a test compound or a selection of test compounds (libraries) and iii) selecting one or more compounds based on its ability to bind one or more receptors. The step of expressing the one or more receptors comprises capturing one or more receptors on the exterior cell surface in a conformation that predominantly enables binding or interaction with a ligand, and the conformation that predominantly enables binding or interaction with a ligand is provided by modification of one or more receptors by a method comprising at least one of the following: (a) fusion with any protein which keeps the receptor in the desired conformation such as, e.g. an arrestin, a modified arrestin, a G-protein or a modified G-protein, (b) site-directed mutagenesis, and (c) deletion. The receptors may be captured on the exterior cell surface by at least one of the following: (d) interaction of the receptor with a scaffolding protein, optionally, with a scaffolding protein network and (e) means for blocking receptor internalization, e.g. by co-expression of a mutated dynamin or a modified arrestin or by use of chemicals such as, e.g., sucrose and/or Tris.
    • 10. 发明申请
    • USE OF A SIGNAL TRANSDUCTION COMPLEX IN DRUG DISCOVERY PROCESSES
    • 在药物发现过程中使用信号传导复合物
    • WO2003056329A2
    • 2003-07-10
    • PCT/DK2002/000901
    • 2002-12-20
    • 7TM PHARMA A/SSCHWARTZ, Thue, W.LANGE, Birgitte, HolstHEYDORN, ArneJØRGENSEN, Rasmus
    • SCHWARTZ, Thue, W.LANGE, Birgitte, HolstHEYDORN, ArneJØRGENSEN, Rasmus
    • G01N33/50
    • C12Q1/00G01N33/50
    • A drug discovery process for identification of a ligand that is able to bind to a biological target molecule, the process comprising a) constructing a signal transduction complex comprising a biological target molecule, one or more downstream effector molecules and, optionally, an adaptor protein, and b) contacting the ligand with the signal transduction complex, and c) measuring any effect resulting from a signal transduction process relating to the biological target molecule and one or more of the downstream effector molecules. A drug discovery process, wherein the signal transduction complex comprises a first component comprising a biological target molecule, a second component comprising one or more adaptor protein(s) and a third component comprising one or more downstream effector molecule(s), wherein each of the components recognizes or binds at least one of the other components to effect a signal transduction process, and wherein at least one of the components has been modified to contain one or more domains and/or one or more recognition motifs.
    • 用于鉴定能够结合生物靶分子的配体的药物发现方法,所述方法包括构建包含生物靶分子,一个或多个下游效应分子和任选的衔接蛋白的信号转导复合物,和 b使配体与信号转导复合体接触,以及c测量由与生物靶分子和一个或多个下游效应分子相关的信号转导过程产生的任何影响。 一种药物发现方法,其中所述信号转导复合物包含包含生物靶分子的第一组分,包含一种或多种衔接蛋白的第二组分和包含一种或多种下游效应分子的第三组分,其中每种组分识别或结合于 影响信号转导过程的其它组分中的至少一种,并且其中至少一种组分已被修饰以含有一个或多个结构域和/或一个或多个识别基序。